Symptoms and QOL in breast cancer patients receiving hormone therapy in Japan

Iioka, Yukiko; Iwata, Takako; Yamauchi, Hideko

doi:10.1007/s12282-019-00993-0

Cited by 10 publications

(4 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The Korean version of the Hospital Anxiety and Depression Scale (HADS) 21 was purchased and used. The HADS was developed for patient populations and has been used in breast cancer patients 22–24 . The HADS consists of 2 subscales, that is, anxiety and depression.…”

Section: Methodsmentioning

confidence: 99%

“…The HADS was developed for patient populations and has been used in breast cancer patients. [22][23][24] The HADS consists of 2 subscales, that is, anxiety and depression. Each item is measured on a 4-point Likert scale (0-3), and the total score of each subscale ranges from 0 to 21, with a higher score indicating greater anxiety and depression levels.…”

Section: Anxiety and Depressionmentioning

confidence: 99%

See 1 more Smart Citation

Do COVID-19–Related Treatment Changes Influence Fear of Cancer Recurrence, Anxiety, and Depression in Breast Cancer Patients?

Kim

2021

Cancer Nurs

View full text Add to dashboard Cite

BackgroundThe worldwide spread of the coronavirus disease 2019 (COVID-19) has impacted the treatment of cancer patients. Treatment changes can negatively affect patients’ prognosis and may be psychologically burdensome.ObjectiveThe aim of this study was to explore whether COVID-19–related treatment changes (delays, cancellations, changes) influenced fear of cancer recurrence, anxiety, and depression in breast cancer patients.MethodsA convenience sample (n = 154) of patients who were diagnosed with breast cancer no longer than 2 years ago was obtained from an online community and social network site. The survey content included COVID-19–related treatment experiences and psychological status. The data were analyzed using descriptive statistics, χ2 test, independent t test, and analysis of variance.ResultsTwenty-nine patients (18.8%) had experienced COVID-19–related treatment changes, and changes of the treatment plan had a significant correlation with depression (t = 2.000, P = .047). Fear of cancer recurrence was high (mean score, 84.31 ± 24.23). Fifteen percent had moderate to severe levels of anxiety, and 24.7% had moderate to severe levels of depression. Narrative reports also identified COVID-19–related unforeseen costs.ConclusionIn the midst of the COVID-19 pandemic, breast cancer patients experienced treatment changes, and changes in treatment plans were significantly associated with depression. Fear of recurrence, anxiety, and depression were found at high levels.Implications for PracticeOncology nurses should assess the psychological status of cancer patients in the early survivorship phase who appear to be especially vulnerable during the COVID-19 pandemic. Oncology nurses can also monitor whether patients are receiving timely supportive care to alleviate fears and anxiety and assess financial needs for COVID-19–related costs.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Anxiety and Depressionmentioning

confidence: 99%

Do COVID-19–Related Treatment Changes Influence Fear of Cancer Recurrence, Anxiety, and Depression in Breast Cancer Patients?

Kim

2021

Cancer Nurs

View full text Add to dashboard Cite

show abstract

“…Patients with breast cancer undergoing hormone therapy might experience serious psychological symptoms (Iioka et al, 2020). Preliminary results of the RCT indicated that the use of SMQOL during breast cancer treatment with chemotherapy might lead to more frequent discussions of health-related QOL topics, especially regarding psychosocial and breast cancer-specific issues (Lugtenberg et al, 2020).…”

Section: Discussionmentioning

confidence: 99%

Effects of a Self-Monitoring Quality of Life Intervention in Outpatients with Breast Cancer: A Preliminary Report of A Randomized Controlled Trial

Matsuda

Inoue

Momiyama

et al. 2022

Asian Pac J Cancer Prev

View full text Add to dashboard Cite

Objective: This preliminary report used data from a randomized controlled clinical trial to investigate the beneficial effects of a self-monitoring quality of life (SMQOL) intervention on communication, medical care and patient outcomes in Japanese women with breast cancer. Methods: This study compared a SMQOL intervention group with a control group that received usual care after 4 months on self-efficacy aspects of patient–physician communication among outpatients with breast cancer in Japan using the Perceived Efficacy in Patient–Physician Interactions (PEPPI) questionnaire. Patients were randomly assigned to the intervention and control groups using permuted-block randomization. The intervention groups were asked to complete a paper-based quality-of-life (QOL) questionnaire in addition to the usual care provided in the control group. Analysis of covariance was used to assess the difference in PEPPI scores between the intervention and control groups. Additionally, subgroup analyses were performed for outpatients with breast cancer accompanied by depression or anxiety. Results: In total, 232 patients were eligible for this study and randomized. Seven patients did not answer the PEPPI questionnaire at baseline after group allocation, leaving 225 patients for inclusion in the analyses. The modified intention-to-treat ITT analysis showed the SMQOL intervention had no significant effect on PEPPI total score (P = 0.226). We found a significant between-group difference in PEPPI total score in the anxiety group (P = 0.045), namely, the self-efficacy aspects of patient–physician communication of those with anxiety in the intervention group were better than for those in the control group after 4 months. Conclusion: Use of the SMQOL had beneficial effects on communication self-efficacy between patients and physicians for outpatients with breast cancer, those with anxiety.

show abstract

“…It has been suggested that worsening QoL might be related to worsened prognosis and an increase in the risk of recurrence. 3 Over the past decades, research has shown that breast cancer and its treatment have a significant emotional and social impact on patients, 4 their QoL 5,6 as well as their capacity for work. [7][8][9] Many survivors experience prolonged adverse physical, cognitive, and psychological effects.…”

Section: Introductionmentioning

confidence: 99%

Development of the Breast Cancer Survivors Symptom Checklist for Use in Follow-Up Multidisciplinary Appointments

Schou-Bredal¹,

Sørensen²,

Kraglund³

et al. 2022

PROM

View full text Add to dashboard Cite

Background Breast cancer survivors are primarily followed up to monitor the effectiveness of treatment and complications and to detect recurrences. Many breast cancer survivors may experience prolonged adverse physical and psychological effects, which should also be addressed at follow-ups. The objective of this study was to develop a brief symptom assessment tool for breast cancer survivors to be used as a guideline for the survivors and all health care professionals conducting the routine follow-up. The second objective was to describe the women’s individual experiences with follow-ups. Methods A literature review, a focus group of 6 healthcare professionals using a nominal group technique process, and the experience and feedback via qualitative interviews with 16 breast cancer survivors was used to develop the Breast Cancer Survivors Symptom Assessment Checklist (BCS-SC). Results The BCS-SC consists of a set of 13 symptoms/burdens and one question. On a scale from 0 (no symptom) to 10 (worst imaginable), survivors indicated the extent to which they experience each symptom. All survivors perceived the annual follow-ups as important, but none prepared for them. Eight of the 16 survivors reported that they had 2 or more of the symptoms/burdens listed in the BCS-SC. However, only one of the survivors had mentioned her symptom to the doctor at follow-up. Conclusion The BCS-SC is a comprehensive assessment tool for symptoms/burdens that are common among breast cancer survivors and can aid efforts to optimize their follow-up. Furthermore, the BCS-SC allows for a more patient-initiated and focused consultation, leading to more patient-centered quality care.

show abstract

Symptoms and QOL in breast cancer patients receiving hormone therapy in Japan

Cited by 10 publications

References 5 publications

Do COVID-19–Related Treatment Changes Influence Fear of Cancer Recurrence, Anxiety, and Depression in Breast Cancer Patients?

Do COVID-19–Related Treatment Changes Influence Fear of Cancer Recurrence, Anxiety, and Depression in Breast Cancer Patients?

Effects of a Self-Monitoring Quality of Life Intervention in Outpatients with Breast Cancer: A Preliminary Report of A Randomized Controlled Trial

Development of the Breast Cancer Survivors Symptom Checklist for Use in Follow-Up Multidisciplinary Appointments

Contact Info

Product

Resources

About